Product Information

CARVEDILOL 6.25 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0181 per EA under NDC 72888003501. Its NADAC has been published 217 times since Jun 29, 2022.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 6.25 MG TABLET

CARVEDILOL
$0.0181per EA

Strength

6.25 mg/1

NDC

72888003501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078165

FDA Approved

9/5/2007

TE Code

AB

On Market Since

7/29/2021

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 6.25 MG TABLET has been published 217 times since Jun 29, 2022, and over the history we have for it it has declined 12.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0181 per EA
All-time high$0.0213 (Sep 13, 2023)
All-time low$0.0155 (Nov 20, 2024)
52-week high$0.0187
52-week low$0.0181
Median price$0.0193
Average price$0.0193
Largest weekly change-21.2% (Nov 20, 2024)
Weeks tracked217
Tracking sinceJun 29, 2022

Price History

1W

-1.5%

1M

-1.5%

3M

-3.1%

6M

-2.1%

1Y

-3.4%

3Y

-11.6%

5Y

N/A

All

-12.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CARVEDILOL 6.25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 6.25 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0181 per EA (NDC 72888003501), effective Aug 19, 2026.

How has the price of CARVEDILOL 6.25 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 6.25 MG TABLET has declined 12.3%. It has been tracked across 217 weekly CMS publications since Jun 29, 2022.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 6.25 MG TABLET?

Since Jun 29, 2022, the NADAC for CARVEDILOL 6.25 MG TABLET has ranged from a low of $0.0155 (Nov 20, 2024) to a high of $0.0213 (Sep 13, 2023), with a median of $0.0193 per EA.

Are there cheaper alternatives to CARVEDILOL 6.25 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 6.25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 6.25 MG TABLET?

CARVEDILOL 6.25 MG TABLET (NDC 72888003501) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.